{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T15:33:07Z","timestamp":1758814387055},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2015,9,2]],"date-time":"2015-09-02T00:00:00Z","timestamp":1441152000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Trials"],"published-print":{"date-parts":[[2015,12]]},"DOI":"10.1186\/s13063-015-0921-9","type":"journal-article","created":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T19:34:24Z","timestamp":1441136064000},"update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["A multi-centre, parallel group superiority trial of silk therapeutic clothing compared to standard care for the management of eczema in children (CLOTHES Trial): study protocol for a randomised controlled trial"],"prefix":"10.1186","volume":"16","author":[{"given":"Eleanor F.","family":"Harrison","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rachel H.","family":"Haines","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fiona","family":"Cowdell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tracey H.","family":"Sach","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Taraneh","family":"Dean","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ian","family":"Pollock","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nigel P.","family":"Burrows","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hannah","family":"Buckley","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jonathan","family":"Batchelor","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hywel C.","family":"Williams","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sandra","family":"Lawton","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sara J.","family":"Brown","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lucy E.","family":"Bradshaw","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amina","family":"Ahmed","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alan A.","family":"Montgomery","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eleanor J.","family":"Mitchell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kim S.","family":"Thomas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2015,9,2]]},"reference":[{"issue":"6","key":"921_CR1","doi-asserted-by":"publisher","first-page":"1251","DOI":"10.1016\/j.jaci.2009.10.009","volume":"124","author":"JA Odhiambo","year":"2009","unstructured":"Odhiambo JA, Williams HC, Clayton TO, Robertson CF, Asher MI. Global variations in prevalence of eczema symptoms in children from ISAAC Phase Three. J Allergy Clin Immunol. 2009;124(6):1251\u20138. doi: 10.1016\/j.jaci.2009.10.009.e23 .","journal-title":"J Allergy Clin Immunol"},{"key":"921_CR2","volume-title":"Atopic eczema \u2013 Treatment","author":"NHS","year":"2014","unstructured":"NHS. Atopic eczema \u2013 Treatment. 2014. http:\/\/www.nhs.uk\/Conditions\/Eczema-(atopic)\/Pages\/Treatment.aspx . Accessed 31 March 2015."},{"key":"921_CR3","volume-title":"British National Formulary (online)","author":"Joint Formulary Committee","year":"2015","unstructured":"Joint Formulary Committee. British National Formulary (online). London: BMJ Group and Pharmaceutical Press; 2015. http:\/\/www.medicinescomplete.com . Accessed 22 April 2015."},{"issue":"8","key":"921_CR4","doi-asserted-by":"publisher","first-page":"e901","DOI":"10.1111\/j.1365-2230.2009.03672.x","volume":"34","author":"C Vlachou","year":"2009","unstructured":"Vlachou C, Thomas KS, Williams HC. A case report and critical appraisal of the literature on the use of DermaSilk in children with atopic dermatitis. Clin Exp Dermatol. 2009;34(8):e901\u20133.","journal-title":"Clin Exp Dermatol"},{"issue":"6","key":"921_CR5","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1111\/pai.12111","volume":"24","author":"C Lopes","year":"2013","unstructured":"Lopes C, Silva D, Delgado L, Correia O, Moreira A. Functional textiles for atopic dermatitis: a systematic review and meta-analysis. Pediatr Allergy Immunol. 2013;24(6):603\u201313. doi: 10.1111\/pai.12111 .","journal-title":"Pediatr Allergy Immunol"},{"issue":"1","key":"921_CR6","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1186\/s12895-015-0024-z","volume":"15","author":"H Nankervis","year":"2015","unstructured":"Nankervis H, Devine A, Williams HC, Ingram JR, Doney E, Delamere F, et al. Validation of the global resource of eczema trials (GREAT database). BMC Dermatol. 2015;15(1):24. doi: 10.1186\/s12895-015-0024-z .","journal-title":"BMC Dermatol"},{"issue":"5","key":"921_CR7","doi-asserted-by":"publisher","first-page":"534","DOI":"10.1111\/j.1468-3083.2006.01526.x","volume":"20","author":"A Gauger","year":"2006","unstructured":"Gauger A, Fischer S, Mempel M, Schaefer T, Foelster-Holst R, Abeck D, et al. Efficacy and functionality of silver-coated textiles in patients with atopic eczema. J Eur Acad Dermatol Venereol. 2006;20(5):534\u201341. doi: 10.1111\/j.1468-3083.2006.01526.x .","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"4","key":"921_CR8","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1185\/030079906X99990","volume":"22","author":"M Juenger","year":"2006","unstructured":"Juenger M, Ladwig A, Staecker S, Arnold A, Kramer A, Daeschlein G, et al. Efficacy and safety of silver textile in the treatment of atopic dermatitis (AD). Curr Med Res Opin. 2006;22(4):739\u201350. doi: 10.1185\/030079906X99990 .","journal-title":"Curr Med Res Opin"},{"issue":"4","key":"921_CR9","doi-asserted-by":"publisher","first-page":"268","DOI":"10.3109\/15569527.2013.775655","volume":"32","author":"CP Ara\u00fajo","year":"2013","unstructured":"Ara\u00fajo CP, Gomes J, Vieira AP, Ventura F, Fernandes JC, Brito C. A proposal for the use of new silver-seaweed-cotton fibers in the treatment of atopic dermatitis. Cutan Ocul Toxicol. 2013;32(4):268\u201374. doi: 10.3109\/15569527.2013.775655 .","journal-title":"Cutan Ocul Toxicol"},{"issue":"4","key":"921_CR10","doi-asserted-by":"publisher","first-page":"438","DOI":"10.5021\/ad.2012.24.4.438","volume":"24","author":"SH Kim","year":"2012","unstructured":"Kim SH, Hwang SH, Hong SK, Seo JK, Sung HS, Park SW, et al. The clinical efficacy, safety and functionality of anion textile in the treatment of atopic dermatitis. Ann Dermatol. 2012;24(4):438\u201343. doi: 10.5021\/ad.2012.24.4.438 .","journal-title":"Ann Dermatol"},{"issue":"4","key":"921_CR11","first-page":"7","volume":"7","author":"M Ozawa","year":"2008","unstructured":"Ozawa M. Effect of underwear made from MEDIELE on skin barrier function of atopic dermatitis patients in winter season. Skin Res. 2008;7(4):7.","journal-title":"Skin Res"},{"issue":"7","key":"921_CR12","first-page":"611","volume":"46","author":"Y Yokoyama","year":"2009","unstructured":"Yokoyama Y, Kimata H, Mitarai S, Hirano S, Shirakawa T. Ethylene vinyl alcohol (EVOH) fiber compared to cotton underwear in the treatment of childhood atopic dermatitis: a double-blind randomized study. Indian Pediatr. 2009;46(7):611\u20134.","journal-title":"Indian Pediatr"},{"issue":"4","key":"921_CR13","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1111\/j.1399-3038.2006.00511.x","volume":"18","author":"DY Koller","year":"2007","unstructured":"Koller DY, Halmerbauer G, Bock A, Engstler G. Action of a silk fabric treated with AEGIS in children with atopic dermatitis: a 3-month trial. Pediatr Allergy Immunol. 2007;18(4):335\u20138. doi: 10.1111\/j.1399-3038.2006.00511.x .","journal-title":"Pediatr Allergy Immunol"},{"issue":"3","key":"921_CR14","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1159\/000141648","volume":"217","author":"G Stinco","year":"2008","unstructured":"Stinco G, Piccirillo F, Valent F. A randomized double-blind study to investigate the clinical efficacy of adding a non-migrating antimicrobial to a special silk fabric in the treatment of atopic dermatitis. Dermatology. 2008;217(3):191\u20135. doi: 10.1159\/000141648 .","journal-title":"Dermatology"},{"issue":"3","key":"921_CR15","first-page":"293","volume":"148","author":"C Fontanini","year":"2013","unstructured":"Fontanini C, Berti I, Monasta L, Longo G. DermaSilk in long-term control of infantile atopic dermatitis: a double blind randomized controlled trial. G Ital Dermatol Venereol. 2013;148(3):293\u20137.","journal-title":"G Ital Dermatol Venereol"},{"issue":"3","key":"921_CR16","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1111\/j.1365-2133.1994.tb08530.x","volume":"131","author":"H Williams","year":"1994","unstructured":"Williams H, Burney P, Hay R, Archer C, Shipley M, Hunter J, et al. The UK working party\u2019s diagnostic criteria for atopic dermatitis. I. Derivation of a minimum set of discriminators for atopic dermatitis. Br J Dermatol. 1994;131(3):383\u201396.","journal-title":"Br J Dermatol"},{"key":"921_CR17","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1046\/j.1365-2133.2000.03300.x","volume":"142","author":"RM Emerson","year":"2000","unstructured":"Emerson RM, Charman CR, Williams HC. The Nottingham Eczema Severity Score: preliminary refinement of the Rajka and Langeland grading. Br J Dermatol. 2000;142:288\u201397.","journal-title":"Br J Dermatol"},{"key":"921_CR18","volume-title":"NICE clinical guideline 57: Management of atopic eczema in children from birth up to the age of 12 years. Department of Health","author":"NICE","year":"2007","unstructured":"NICE. NICE clinical guideline 57: Management of atopic eczema in children from birth up to the age of 12 years. Department of Health. 2007."},{"issue":"9","key":"921_CR19","doi-asserted-by":"publisher","first-page":"1111","DOI":"10.1111\/j.1398-9995.2012.02874.x","volume":"67","author":"J Schmitt","year":"2012","unstructured":"Schmitt J, Spuls P, Boers M, Thomas K, Chalmers J, Roekevisch E, et al. Towards global consensus on outcome measures for atopic eczema research: results of the HOME II meeting. Allergy. 2012;67(9):1111\u20137. doi: 10.1111\/j.1398-9995.2012.02874.x .","journal-title":"Allergy"},{"key":"921_CR20","doi-asserted-by":"crossref","unstructured":"Barbier N, Paul C, Luger T, Allen R, De Prost Y, Papp K, et al. Validation of the Eczema Area and Severity Index for atopic dermatitis in a cohort of 1550 patients from the pimecrolimus cream 1 % randomized controlled clinical trials programme. Br J Dermatol. 2004;150(1):96\u2013102.","DOI":"10.1111\/j.1365-2133.2004.05696.x"},{"issue":"4","key":"921_CR21","doi-asserted-by":"publisher","first-page":"800","DOI":"10.1016\/j.jaci.2014.07.043","volume":"134","author":"J Schmitt","year":"2014","unstructured":"Schmitt J, Spuls PI, Thomas KS, Simpson E, Furue M, Deckert S, et al. The Harmonising Outcome Measures for Eczema (HOME) statement to assess clinical signs of atopic eczema in trials. J Allergy Clin Immunol. 2014;134(4):800\u20137. doi: 10.1016\/j.jaci.2014.07.043 .","journal-title":"J Allergy Clin Immunol"},{"issue":"12","key":"921_CR22","doi-asserted-by":"publisher","first-page":"1513","DOI":"10.1001\/archderm.140.12.1513","volume":"140","author":"C Charman","year":"2004","unstructured":"Charman C, Venn A, Williams H. The Patient-Oriented Eczema Measure: development and initial validation of a ew tool for measuring atopic eczema severity from the patients\u2019 Perspective. Arch Dermatol. 2004;140(12):1513\u20139.","journal-title":"Arch Dermatol"},{"issue":"5","key":"921_CR23","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1080\/000155599750010256","volume":"79","author":"A Wolkerstorfer","year":"1999","unstructured":"Wolkerstorfer A, de Waard van der Spek FB, Glazenburg EJ, Mulder PG, Oranje AP. Scoring the severity of atopic dermatitis: three item severity score as a rough system for daily practice and as a pre-screening tool for studies. Acta Derm Venereol. 1999;79(5):356\u20139.","journal-title":"Acta Derm Venereol"},{"key":"921_CR24","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1046\/j.1365-2133.1998.02034.x","volume":"138","author":"V Lawson","year":"1998","unstructured":"Lawson V, Lewis-Jones S, Finlay A, Reid P, Owens R. The family impact of childhood atopic dermatitis: the dermatitis family impact questionnaire. Br J Dermatol. 1998;138:107\u201313.","journal-title":"Br J Dermatol"},{"issue":"2","key":"921_CR25","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1111\/j.1365-2133.2005.06736.x","volume":"153","author":"KJ Stevens","year":"2005","unstructured":"Stevens KJ, Brazier JE, McKenna SP, Doward LC, Cork MJ. The development of a preference-based measure of health in children with atopic dermatitis. Br J Dermatol. 2005;153(2):372\u20137. doi: 10.1111\/j.1365-2133.2005.06736.x .","journal-title":"Br J Dermatol"},{"issue":"8","key":"921_CR26","doi-asserted-by":"publisher","first-page":"729","DOI":"10.2165\/11599120-000000000-00000","volume":"30","author":"K Stevens","year":"2012","unstructured":"Stevens K. Valuation of the Child Health Utility 9D Index. Pharmacoeconomics. 2012;30(8):729\u201347. doi: 10.2165\/11599120-000000000-00000 .","journal-title":"Pharmacoeconomics"},{"key":"921_CR27","unstructured":"CLOTHES Trial. 2015. http:\/\/www.nottingham.ac.uk\/clothes . Accessed 6 August 2015."},{"key":"921_CR28","volume-title":"Unit costs of health and social care. Personal social services research unit: Canterbury","author":"PSSRU","year":"2004","unstructured":"PSSRU. Unit costs of health and social care. Personal social services research unit: Canterbury. 2004."},{"issue":"5","key":"921_CR29","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1002\/hec.944","volume":"14","author":"A Manca","year":"2005","unstructured":"Manca A, Hawkins N, Sculpher MJ. Estimating mean QALYs in trial-based cost-effectiveness analysis: the importance of controlling for baseline utility. Health Econ. 2005;14(5):487\u201396. doi: 10.1002\/hec.944 .","journal-title":"Health Econ"}],"container-title":["Trials"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13063-015-0921-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s13063-015-0921-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13063-015-0921-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,6,23]],"date-time":"2017-06-23T18:43:57Z","timestamp":1498243437000},"score":1,"resource":{"primary":{"URL":"http:\/\/trialsjournal.biomedcentral.com\/articles\/10.1186\/s13063-015-0921-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,9,2]]},"references-count":29,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2015,12]]}},"alternative-id":["921"],"URL":"https:\/\/doi.org\/10.1186\/s13063-015-0921-9","relation":{},"ISSN":["1745-6215"],"issn-type":[{"value":"1745-6215","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,9,2]]},"article-number":"390"}}